The FDA has approved the First Hormone Blockading Drug for Advanced Prostate Cancer

FDA just approved th first gonsdotropin-releasing hormone (GnRH) drug for the treatment of Advanced Prostate Cancer. This newly approved gonadotropin-releasing hormone (GnRH) receptor antagonist demonstrates rapid, long-term suppression of testosterone. Ferring Pharmaceuticals, USA (FP) received approval from the U.S. Food and Drug Administration (FDA) for degarelix, (generic name) which is a new injectable gonadotropin-releasing hormone [...]

FDA Approves New Drug to Alleviate Moderate to Severe Pain

The U.S. Food and Drug Administration (FDA) has approved a new drug which provides relief of moderate to severe acute pain. This is great news for us, because, advanced prostate cancer often brings pain from mets and breaking bones. This newly approved drug, tapentadol hydrochloride, is delivered as an immediate-release oral tablet. It is a [...]

The Sorry State Of Affairs With Advanced Prostate Cancer Research

I extracted the following from a news release published today about a new potential vaccine therapy for advanced prostate cancer. My reason for republishing it is not for the informational value, but is to share my feelings about the sorry state of prostate cancer treatment. Please read the press release and then my comments that [...]

Identifying That Tumor, Is It A Metastasis or A New Cancer?

Coincidentally, when I experienced my PSA recurrence of prostate cancer my rheumatologist suggested that I have an MRI to check up on the status of spinal involvement from my arthritis. After going through the usual struggles with the insurance company, I did have the MRI. While still dealing with the emotional issues of learning about [...]

Go to Top